The oncogenic Epstein-Barr virus (EBV)-encoded latent infection membrane protein 1 (LMP1) constitutively activates the 'canonical' NF-jB pathway that involves the phosphorylation and degradation of IjBa downstream of the IjB kinases (IKKs). In this study, we show that LMP1 also promotes the proteasome-mediated proteolysis of p100 NF-jB2 resulting in the generation of active p52, which translocates to the nucleus in complex with the p65 and RelB NF-jB subunits. LMP1-induced NF-jB transactivation is reduced in nf-kb2 À/À mouse embryo fibroblasts, suggesting that p100 processing contributes to LMP1-mediated NF-jB transcriptional effects. This pathway is likely to operate in vivo, as the expression of LMP1 in primary EBV-positive Hodgkin's lymphoma and nasopharyngeal carcinoma biopsies correlates with the nuclear accumulation of p52. Interestingly, while the ability of LMP1 to activate the canonical NF-jB pathway is impaired in cells lacking IKKc/NEMO, the regulatory subunit of the IKK complex, p100 processing remains unaffected. As a result, nuclear translocation of p52, but not p65, occurs in the absence of IKKc. These data point to the existence of a novel signalling pathway that regulates NF-jB in LMP1-expressing cells, and may thereby play a role in both oncogenic transformation and the establishment of persistent EBV infection.
The oncogenic Epstein-Barr virus (EBV)-encoded latent infection membrane protein 1 (LMP1) constitutively activates the 'canonical' NF-jB pathway that involves the phosphorylation and degradation of IjBa downstream of the IjB kinases (IKKs). In this study, we show that LMP1 also promotes the proteasome-mediated proteolysis of p100 NF-jB2 resulting in the generation of active p52, which translocates to the nucleus in complex with the p65 and RelB NF-jB subunits. LMP1-induced NF-jB transactivation is reduced in nf-kb2 À/À mouse embryo fibroblasts, suggesting that p100 processing contributes to LMP1-mediated NF-jB transcriptional effects. This pathway is likely to operate in vivo, as the expression of LMP1 in primary EBV-positive Hodgkin's lymphoma and nasopharyngeal carcinoma biopsies correlates with the nuclear accumulation of p52. Interestingly, while the ability of LMP1 to activate the canonical NF-jB pathway is impaired in cells lacking IKKc/NEMO, the regulatory subunit of the IKK complex, p100 processing remains unaffected. As a result, nuclear translocation of p52, but not p65, occurs in the absence of IKKc. These data pointIntroduction Epstein-Barr virus (EBV) is a human herpesvirus that infects most individuals but remains predominantly asymptomatic. However, EBV can also contribute to oncogenesis as evidenced by its frequent detection in a number of human tumors, including Burkitt's and posttransplant B-cell lymphomas, Hodgkin's disease and nasopharyngeal carcinomas (NPCs) and by its unique ability to transform normal B lymphocytes in vitro into permanently growing lymphoblastoid cell lines (LCLs) (Rickinson and Kieff, 1996) . These oncogenic effects are associated with the restricted expression of EBV genes such that only a subset of the so-called latent viral proteins are expressed in LCLs and EBV-positive tumors. Among these viral proteins, the latent infection membrane protein 1 (LMP1) has attracted much attention because of its ability to transform rodent fibroblast cell lines and drive the immortalization of primary human B lymphocytes in vitro (Kaye et al., 1993) . Moreover, targeted expression of LMP1 in the Bcell or epithelial compartment of transgenic mice results in oncogenesis (Wilson et al., 1990; Kulwichit et al., 1998) .
Many of the oncogenic effects of LMP1 can be explained by its ability to engage signalling pathways constitutively, such as the JNK and p38 mitogenactivated protein kinases (MAPKs), the PI3 kinase and the NF-kB cascade, among others (Dawson et al., 2003 ; reviewed by Eliopoulos and Young, 2001) . The effects of LMP1 on NF-kB are of particular importance given the key role of this family of transcription factors in regulating diverse biological effects, such as inflammation, cell growth, differentiation and survival. Indeed, the constitutive engagement of NF-kB appears to be responsible for many of the oncogenic properties of LMP1 in vitro, including its ability to growth transform Rat-1 fibroblasts (He et al., 2000) , to upregulate antiapoptotic proteins (Fries et al., 1996) and to induce the expression of angiogenic factors and cell surface markers associated with motility and invasion (Eliopoulos et al., 1999 (Eliopoulos et al., , 2002a Murono et al., 2001) . Moreover, genetic and biochemical analyses link LMP1-mediated NF-kB activation to B-cell transformation. Thus, a mutated recombinant EBV lacking the cytoplasmic tail of LMP1 is severely impaired in its ability to activate NF-kB and to immortalize primary B lymphocytes in vitro (Kaye et al., 1995) , and suppression of NF-kB compromises the viability of established EBV-transformed B-cell lines (Cahir-McFarland et al., 2000) .
The cytoplasmic C-terminus of LMP1 transduces NF-kB signals via its interaction with the adapter proteins TRADD and TRAF2, which, in turn, recruit a multiprotein catalytic complex containing the NF-kBinducing kinase (NIK) and the IkB kinases (IKKs), among others (Izumi and Kieff, 1997; Sylla et al., 1998; Izumi et al., 1999) . The IKKs comprise two catalytic subunits, IKKa (IKK1) and IKKb (IKK2), and a regulatory subunit, IKKg/NEMO (reviewed in Ghosh and Karin, 2002) . The activation of the IKK complex by cytokines, proinflammatory stimuli and kinases, such as NIK, induces the phosphorylation and subsequent degradation of IkBa, an inhibitory molecule that resides in the cytoplasm and prevents entry of p65 (RelA) : p50 NF-kB dimers to the nucleus. LMP1 is known to activate NF-kB via the phosphorylation and degradation of IkBa, but the precise physiological role of the IKK complex in this LMP1-mediated effect is poorly understood (Herrero et al., 1995; Sylla et al., 1998) . Moreover, the ability of LMP1 to activate NF-kB through the mobilization of NF-kB subunits other than p65 and p50 is widely unknown. Recent biochemical and genetic evidence suggests an important role for the p52 NF-kB subunit in lymphoid development and survival that cannot be replaced by p50 or other NF-kB members (Caamano et al., 1998; Franzoso et al., 1998) . Generation of p52 occurs through the inducible post-and cotranslational processing of its inactive precursor, p100 NF-kB2 (Xiao et al., 2001b; Mordmuller et al., 2003) . NIK is the only MAP3 kinase found so far to induce the proteolysis of p100 NF-kB2 to p52 and this effect is abolished in a naturally occurring alymphoplasia (aly) mutant NIK (Senftleben et al., 2001; Xiao et al., 2001b) .
In this study, we demonstrate that in addition to the canonical IkBa-p65/p50 NF-kB pathway, LMP1 stimulates the production of p52 through the proteasome-mediated proteolysis of p100 NF-kB2. This effect involves NIK but occurs independently of IKKg/NEMO and results in the translocation of p52 to the nucleus in complex with other NF-kB subunits, such as p65 and RelB. Unlike p100 processing, LMP1-mediated IkBa degradation critically depends on the formation of an IKKg/NEMO-dependent signalling complex.
Results

LMP1 expression correlates with p52 accumulation in vitro and in vivo
We examined the expression of p100 NF-kB2 and its processed product p52 in EBV-positive (Akata, Namalwa, X50-7 and IB4) and EBV-negative (DG75) lymphoid cell lines using immunoblot. Akata and Namalwa are Burkitt lymphoma cell lines with restricted EBV latent gene expression and absence of LMP1, while X50-7 and IB4 represent LCLs that naturally express LMP1 (Figure 1a ). Among these lines, X50-7 and IB4 were found to possess elevated levels of the transcriptionally active p52 NF-kB subunit, compared to LMP1-negative cells ( Figure 1a ). Immunohistochemical (IHC) staining of LMP1-positive L591 and LMP1-negative KMH2 Hodgkin's lymphoma lines for p100 NF-kB2/p52 was also performed, and demonstrated low levels of cytoplasmic NF-kB2 in KMH2 but strong nuclear staining in L591 cells (Figure 1b) . Thus, expression of LMP1 correlates with elevated p52 levels in lymphoma cell lines.
To ascertain whether a similar correlation exists in vivo, we analysed the expression of NF-kB2/p52 and LMP1 in primary biopsies from patients with Hodgkin's disease and NPC, two EBV-associated malignancies, using immunohistochemistry. Representative stained specimens are shown in Figure 2 . Among the nine Hodgkin's lymphoma biopsies analysed, six were EBV positive and found to contain LMP1-positive Hodgkin/ Reed-Stenberg (HRS) cells. These cells strongly stained for nuclear p52, while in the three EBV-negative cases only cytoplasmic NF-kB2 staining in the HRS cells was observed. A total of 11 NPC biopsies were also analysed, all of which were found to be EBV positive, as determined by in situ hybridization for EBV-encoded small nonpolyadenylated RNAs (data not shown). Among these biopsies, four were LMP1 positive and stained strongly for nuclear p52. Six LMP1-negative cases also stained for NF-kB2 to various degrees, but the staining was almost exclusively cytoplasmic ( Figure 2 ). Only one of the LMP1-negative NPC biopsies examined showed elevated nuclear levels of p52, implicating additional factors in NF-kB2 signalling in NPC. Despite the small number of primary biopsies Lysates from the EBV-positive (Akata, Namalwa, X50-7 and IB4) and EBV-negative (DG75) lymphoma cell lines were analysed for LMP1, b-tubulin and p100 NF-kB2 and p52 levels by immunoblot, as indicated. (b) IHC staining for NF-kB2 shows nuclear accumulation of p52 (solid arrow) in L591 but mostly cytoplasmic NF-kB2 staining (dashed arrow) in KMH2 Hodgkin's lymphoma cells. L591 and KMH2 are known to be LMP1 positive and LMP1 negative, respectively (Flavell et al., 2000) analysed, these data demonstrate a good correlation between LMP1 expression and nuclear accumulation of p52 in vivo.
LMP1 induces the proteasome-mediated proteolysis of p100 NF-kB2 to p52
The data presented in Figures 1 and 2 raise the possibility that LMP1 directly regulates the processing of p100 NF-kB2 to p52. To address this issue, we used an ecdysone-inducible LMP1 system expressed in human embryonic kidney (HEK) 293 cells (293EcR/ LMP1 clone 1; Eliopoulos et al., 1999) . In the absence of the ecdysone hormone analogue ponasterone A, no LMP1 expression was detected and only basal levels of p52 were seen ( Figure 3a , lane 1). Following addition of ponasterone A, significant upregulation of LMP1 expression occurred within 6 h of treatment and further increased at later time points. Induction of LMP1 in these cells was accompanied by a significant increase in p52 levels ( Figure 3a , lanes 2-5). The same immunoblots were probed for b-tubulin, which serves as a loading control (Figure 3a) . Quantitation of the ratio of the p52 : p100 levels in three independent experiments confirmed that LMP1 induction consistently promotes the accumulation of p52 (Figure 3b ). Similar results were obtained with an independently isolated 293EcR/LMP1 clone (clone 4, data not shown). To confirm the effects of LMP1 on this pathway, HEK 293T cells were transiently transfected with LMP1 or empty vector and endogenous p100 NFkB2 and p52 were determined by immunoblot. As a positive control (Xiao et al., 2001b) , we used lysates from 293T cells transfected with NIK, a component of LMP1-mediated NF-kB signalling. Transient expression of LMP1 was able to induce p52 accumulation to levels similar to those observed in NIK-transfected cultures (Figure 3c ). Finally, to determine whether stable expression of LMP1 also induces the accumulation of p52, the immortalized but nontumorigenic NP69 human pharyngeal cell line was infected with a retrovirus expressing LMP1 or with control virus. Following selection for cells expressing LMP1, lysates were prepared from three independent clones and examined for endogenous p100 NF-kB2 and p52 levels. In agreement with the effects of inducible or transient LMP1, stable expression of this viral protein also resulted in enhanced p52 accumulation, compared to control cultures (Figure 3d ).
In the experiments described above, the levels of p100 did not decrease in parallel with the accumulation of p52, presumably due to the effects of LMP1 on de novo nf-kb2 gene transcription that occurs in part via the NF-kB pathway. Thus, stimulation of CD40 or the lymphotoxin-b receptor (LTbR) is known to promote the induction of p100 expression in a RelA/p65 NF-kBdependent manner, while the processing of p100 does not require this signalling pathway (Coope et al., 2002; Dejardin et al., 2002) . To confirm that the LMP1-mediated accumulation of p52 is the result of p100 NF-kB2 processing, pulse-chase radiolabelling experiments were performed. To this end, HEK 293EcR/LMP1 cultures were treated with ponasterone A for 18 h to induce the accumulation of LMP1 or left untreated prior to labelling with [ 35 S]methionine. As shown in Figure 4a , only a very small amount of labelled p100 was converted to p52 following a 4 h chase in control untreated cells (lanes 1 and 2). However, in the presence of LMP1, p100 NF-kB2 was efficiently processed to p52 in a time-dependent manner (Figure 4a , LMP1 p100/p52 HL #1 HL #2 NPC #1 NPC #2
Figure 2 LMP1 expression correlates with elevated levels of p52 in vivo. Representative IHC staining for NF-kB2 and LMP1 in one LMP1-positive (HL #1) and one LMP1-negative (HL #2) Hodgkin's lymphoma (HL) biopsy shows significant nuclear accumulation of p52 in the LMP1-positive HRS cells (solid arrow) and cytoplasmic NF-kB2 in the LMP1-negative specimen (dashed arrow). Also shown is representative IHC staining for NF-kB2 and LMP1 in one LMP1-positive (NPC #1) and one LMP1-negative (NPC #2) NPC biopsy. Again, significant levels of nuclear p52 are observed in the LMP1-positive NPC cells (solid arrow) while NF-kB2 staining is predominantly cytoplasmic in the LMP1-negative specimen (dashed arrow). Brown color represents NF-kB2 immunoreactivity and blue is hematoxylin counterstaining LMP1 induces p100 NF-jB2 signalling AG Eliopoulos et al lanes 3-5). Moreover, the LMP1-mediated p100 NF-kB2 processing was inhibited when the cells were treated with the proteasome inhibitor MG132 (Figure 4a , lane 6). This observation was confirmed by experiments in which total lysates from ponasterone A-and MG132-treated HEK 293EcR/LMP1 cultures were analysed for p100 and p52 levels by immunoblot. As shown in Figure 4b , treatment of these cells with MG132 abolished the ability of LMP1 to promote the accumulation of p52. However, inhibition of LMP1-induced p38 MAPK activation by the specific inhibitor SB203580 (Eliopoulos et al., 1999 ) had no effect (Figure 4b ). Taken together, these data suggest that LMP1 induces the proteasome-dependent proteolysis of p100 NF-kB2 to generate p52.
LMP1 induces nuclear translocation of active p52
We next assessed the effects of inducible LMP1 expression on NF-kB activation and the contribution of p52 to this phenomenon by using electrophoretic mobility shift assays (EMSAs). To this end, nuclear proteins isolated from HEK 293EcR/LMP1 cells before and 6 and 24 h after stimulation with ponasterone A were examined for binding to a 32 P-labelled oligonucleotide probe containing the HIV LTR NF-kB-binding site. LMP1 expression was found to promote the induction of NF-kB-binding activity in a time-dependent manner ( Figure 5a , lanes 2-4). The nature and specificity of the NF-kB probe-bound proteins were assessed by incubating nuclear extracts isolated from ponasterone A-stimulated cells with 50 Â excess unlabelled probe containing either the HIV LTR NF-kB consensus or the CREB-binding site from the COX-2 promoter. While the cold NF-kB probe abolished the interaction of 293EcR/LMP1 cell nuclear proteins with the 32 P-labelled HIV LTR probe, excess CREB-binding oligonucleotides had no effect ( Figure 5a , lanes 4-6). The composition of the induced DNA : protein complex was assessed by treatment of the 24 h nuclear extracts with antibodies against the p65 (RelA), p50, p52 and cRel NF-kB subunits. As shown in Figure 5b , the antibodies to p65, p50 and p52 but not cRel supershifted the complex, suggesting that in addition to p65/p50, p52 accumulation. HEK 293EcR/LMP1 cells were treated with ponA for 18 h in the presence or absence of 20 mM of the proteasome inhibitor MG132 or the p38 MAPK inhibitor SB203580, before being analysed for LMP1, b-tubulin and p100 NF-kB2/p52 levels by immunoblot, as indicated. At the concentration used, SB203580 inhibits LMP1-mediated p38 activation (Eliopoulos et al., 1999) contributes to the NF-kB activity in LMP1-expressing cells, comprising approximately 20% of the total NFkB : protein complex. We have also analysed the same nuclear extracts for binding to a 32 P-labelled oligonucleotide probe containing the MHC class I H2 kB element that is known to bind p52 with higher affinity than the HIV kB element (reviewed by Perkins, 1997) . Supershift analysis using antibodies p65 and p52 showed that approximately 40-50% of the H2 kB-bound NF-kB complex contains p52 (Figure 5c ). These findings are in agreement with a previous report that identified p52 as a component of the NF-kB : DNA-binding complex in an epithelial cell line stably transfected with LMP1 (Paine et al., 1995) . However, we did not convincingly observe anti-p52 supershifted complex(es) in EMSA experiments in which nuclear proteins isolated from the 6 h time point were used in conjunction with the HIV LTR probe, although this NF-kB-binding activity responded to antibodies against the p65 and p50 subunits (data not shown). This observation suggests that the nuclear translocation of p52 occurs with slower kinetics than that of p65 NF-kB.
To verify or refute this possibility and confirm the presence of p52 in the nucleus of LMP1-expressing cells, cytoplasmic and nuclear fractions were prepared from 293EcR/LMP1 cells before and after treatment with ponasterone A and immunoblotted for p100 NF-kB2 and p52. In unstimulated cells or in cultures treated with ponasterone A for 6 h, very little p52 was detected in the nuclear fraction (Figure 5d , lanes 4 and 5). However, a dramatic increase in nuclear p52 was observed at 24 h of treatment with ponasterone A (Figure 5d , lane 6). Some p52 was also detected in the cytoplasm of both treated and unstimulated cells (Figure 5c , lanes 1-3), (a) Inducible LMP1 expression results in increased NF-kB DNAbinding activity. HEK 293EcR/LMP1 cells were treated for 6 or 24 h with 10 mM ponasterone A or left untreated. Nuclear proteins were isolated and examined for binding to a 32 P-labelled oligonucleotide probe containing the HIV LTR NF-kB-binding site. The interaction of nuclear proteins with the probe was abolished in the presence of 50 Â excess unlabelled (cold) HIV LTR NF-kB oligo, but remained unaffected by excess (50 Â ) of an oligonucleotide containing the CREB-binding site from the COX-2 promoter. (b and c) p52 is a component of the LMP1-induced NFkB-binding activity. The composition of the protein complex bound to a 32 P-labelled HIV LTR (b) or MHC class I (c) NF-kB oligonucleotide probe was assessed by treatment of the 24 h nuclear extracts with antibodies against the p65 (RelA), p50, p52 and cRel NF-kB subunits, as indicated. Supershifted complexes are indicated by stars. (d) Nuclear translocation of p52, p65 and RelB following inducible expression of LMP1. Cytoplasmic and nuclear proteins isolated from HEK 293EcR/LMP1 cells before and 6 or 24 h after stimulation with ponasterone A were examined for expression of p100 NF-kB2/p52, p65 and RelB. Immunoblotting for tubulin, a cytoplasmic marker, and SP1, a nuclear marker, confirmed cell fractionation. (e) LMP1 induces the nuclear translocation of p52 in complex with p65 and RelB. Nuclear proteins isolated from HEK 293EcR/LMP1 cells before and 24 h after stimulation with ponasterone A were immunoprecipitated (IP) with anti-p65 or anti-RelB polyclonal antibody and immunoblotted (IB) with an anti-p100 NF-kB2 monoclonal. p52 was found to interact with p65 and RelB in LMP1-expressing (lanes 2 and 4) but not in control untreated 293EcR/LMP1 cells (lanes 1 and 3) LMP1 induces p100 NF-jB2 signalling AG Eliopoulos et al probably due to complexing with IkB molecules. Consistent with this possibility, cytoplasmic p52 interacts with IkBa in CD40-stimulated B cells (Coope et al., 2002) . Immunoblotting of the same lysates with an antitubulin antibody was used to control cytoplasmic contamination in the nuclear fractions, and the absence of nuclear contamination in cytoplasmic extracts was verified by blotting for SP1, a nuclear marker (Figure 5d ). The same lysates were also examined for expression of p65 (RelA) and RelB. An increase in the levels of nuclear RelB was observed following ponasterone A treatment, in parallel with the accumulation of p52. There was also a significant increase in the accumulation of nuclear p65, which occurred with accelerated kinetics compared to p52 and RelB. Significant levels of p65 were also observed in the cytoplasmic fraction of both untreated and ponasterone A-treated cultures, reflecting the presence of IkBabound p65 molecules in the cytoplasm of these cells (Figure 5d, lanes 1-3) .
We then examined whether LMP1 promotes the association of p52 with p65 and/or RelB. To this end, nuclear proteins isolated from HEK 293EcR/LMP1 cells before and 24 h after stimulation with ponasterone A were immunoprecipitated with antibodies against the C-terminus of p65 or RelB and immunoblotted with an anti-p100 NF-kB2 monoclonal antibody (mAb). Both RelB and p65 were found to complex with p52 in LMP1-expressing but not in control uninduced cells where p52 was essentially absent (Figure 5e ). Nuclear p100 (also seen in Figure 5d ) also co-precipitated with RelB, in agreement with recent data suggesting that p100 NF-kB2 plays a role in nuclear entry of RelB (Solan et al., 2002) . These interactions were specific as immunoprecipitation of SP1 from the same nuclear extracts failed to pull down p52 (data not shown). Parallel immunoblot analysis of anti-p52 immunoprecipitates demonstrated that approximately 20-25% of nuclear p52 associates with p65 and approximately 30-35% with RelB (data not shown). Given the limitations of the immunoprecipitation assay, it is possible that these percentages are in fact higher. These findings, coupled with the data described in Figure 3a , suggest that in the absence of LMP1, basal p52 may exist as homodimer and that following LMP1 expression, p52 forms heterodimers with p65/RelA and RelB to transactivate target genes. The ability of p52 to complex with Bcl-3, a nuclear IkB family member that functions with p52 to stimulate transcription, has been previously demonstrated (Nolan et al., 1993) and may account for the remaining amount of LMP1-induced nuclear p52. The role of Bcl-3 in LMP1 signal transduction is currently under investigation.
Reduced NF-kB transactivation in LMP1-transfected nf-kb2 À/À mouse embryo fibroblasts (MEFs)
The results presented in Figure 5 demonstrate that p52 contributes to LMP1-induced NF-kB-binding activity.
To determine the relative contribution of p52 and p65 to the effects of LMP1 on NF-kB transcriptional activation, we used reporter assays in MEFs isolated from p65
, nf-kb2 À/À or wild-type (WT) mice. These cells were first immortalized to enhance their growth and transfection efficiency. Established cultures were transiently transfected with LMP1 or control vector, in the presence of an NF-kB luciferase reporter and a b-galactosidase plasmid to monitor for transfection efficiency. The absence of p65 but not NF-kB2 had a significant inhibitory effect on the basal levels of reporter activity, which were approximately fourfold lower than in WT MEFs. Thus, the ratio of the basal NF-kB transcriptional activities in p65 À/À versus WT cells was 0.26 (70.06, n ¼ 3), while in nf-kb2 À/À versus WT fibroblasts was 1.1 (70.1, n ¼ 3) (data not shown). Expression of LMP1 in WT MEFs induced a 4.5-fold increase in NF-kB transcriptional activity compared to control vector-transfected cells and this effect was significantly reduced but not abrogated in p65
À/À cells (Figure 6a ). Transfection of LMP1 in nf-kb2 À/À MEFs (Caamano et al., 1998) also resulted in reduced NF-kB transactivation, which was approximately 35-40% lower than their WT equivalent. In these reporter assays, LMP1 was expressed at equivalent levels across the transfected MEFs (Figure 6b ) and b-galactosidase values did not differ more than 1.8-fold, excluding an artifactual basis for the observed differences in NF-kB activity. Recent studies have demonstrated that the cyclin D1 promoter contains a p52-responsive NF-kB site (Westerheide et al., 2001; Rocha et al., 2003) . Transient transfection of WT fibroblasts with LMP1 and a cyclin D1 promoter luciferase construct containing the proximal p52-responsive site (À66 CD1-Luc; Albanese et al., 1995) induced a 2.2-fold increase in reporter activity and this effect was inhibited by more than 40% in the nf-kb2 À/À MEFs (Figure 6c ). These data confirm the contribution of the p52 pathway to LMP1-induced NF-kB transcriptional activity and highlight its role in physiological effects.
To verify that the observed signaling defects were particular for NF-kB, we analysed the effects of LMP1 on JNK activation in WT, p65
À/À and nf-kb2 À/À MEFs. Cells were cotransfected with an HA-JNK1 expression vector and LMP1 or control plasmid and cell lysates were analysed for JNK1 activation by immunoblotting using an antibody that specifically recognizes the phosphorylated, active form of JNK or an antibody that detects HA-JNK1 irrespective of its phosphorylation status. The results showed that, unlike NF-kB, LMP1 induces similar levels of JNK activation in WT, p65
À/À and nf-kb2 À/À MEFs (Figure 6d ).
NIK is a component of LMP1-induced p100 NF-kB2 signalling NIK, a TRAF-interacting protein that is recruited to the LMP1 signalling complex, is unique among MAP3Ks in its ability to induce p100 processing in vitro and to be required for p52 production in vitro and in vivo (Xiao et al., 2001b) . A mutated NIK molecule, expressing only its TRAF-interacting C-terminal domain (amino acids (aa) 624-947), is unable to promote p100 processing and functions as a potent inhibitor of WT NIK (Lin et al., 1998; Xiao et al., 2001b) . Indeed, overexpression of NIK[624-947] (NIKD) suppresses CD40-, LTbR-and LMP1-mediated NF-kB transactivation and selectively inhibits the processing of p100 in anti-CD40-stimulated cells (Lin et al., 1998; Luftig et al., 2001; Coope et al., 2002) . We therefore examined whether NIKD affects LMP1-mediated p100 processing. To this end, 293T cells were transiently transfected with LMP1, in the presence or absence of equivalent amounts of NIKD or control vector, and p100/p52 levels were assessed by immunoblot analysis of total cell lysates. It was found that the production of p52 by LMP1 was abolished in cells coexpressing NIKD (Figure 7, lanes 1-3) . As a control for these experiments, NIKD also suppressed CD40-mediated p100 processing (Coope et al., 2002; Figure 7 , lanes 4 and 5). This result suggests that NIK mediates LMP1-induced p100 NF-kB2 signals. processing. An N-terminus-deleted NIK mutant (NIKD) suppresses LMP1-mediated p100 processing. HEK 293T cells (1 Â 10 6 ) were transfected with 5 mg LMP1, in the presence or absence of 5 mg NIKD or control empty vector (vec), and 36 h later cell lysates were examined for LMP1, NIKD, b-tubulin and p100/p52 levels by immunoblot. As a control for these experiments, cells were transfected with 5 mg CD40 in the presence or absence of equivalent amounts of NIKD and stimulated with 5 mg/ml G28.5 anti-CD40 mAb for 12 h prior to lysis and immunoblot analysis in NF-kB activation induced by a number of stimuli (Rothwarf et al., 1998; Yamaoka et al., 1998) .
LMP1-induced
We examined the role of this IKKg-induced macromolecular complex in LMP1-mediated NF-kB signalling. To this end, we stably expressed an inducible LMP1 in WT-and IKKg/NEMO-deficient Rat-1 cells (5R; Yamaoka et al., 1998). The inducible LMP1 system we used was constructed on the basis of previous work, demonstrating that LMP1-mediated signalling requires the oligomerization of its C-terminal portion (Floettmann and Rowe, 1997; Gires et al., 1997) . Thus, a chimera comprising the extracellular and transmembrane domains of CD2 (aa 1-212) fused to the cytoplasmic C-terminus of LMP1 CD2.192LMP1) promotes the activation of NF-kB, JNK and p38 MAPK pathways only upon CD2 crosslinking (Floettmann and Rowe, 1997; Gires et al., 1997; Eliopoulos et al., 1999) . Representative clones from CD2.192LMP1-transfected Rat-1 and 5R cells were examined for expression of the chimaera by flow cytometry following staining with either OX34 anti-CD2 mAb or G28.5 anti-CD40 mAb as a negative control. Rat-1/CD2.192LMP1 clone 4 and 5R/CD2.192LMP1 clone 6 were selected for subsequent experiments on the basis of similar levels of CD2 cell surface expression (Figure 8a ). Cells were stimulated with OX34 anti-CD2 mAb and crosslinking immunoglobulin for various time intervals and lysates were immunoblotted for IkBa or its phosphorylated form. As expected, the induced oligomerization of LMP1 C-terminus in Rat-1/CD2.192LMP1 cells but not in untransfected cultures resulted in rapid IkBa phosphorylation and degradation, which was evident as early as 15 min and maximal at 60 min poststimulation (Figure 8b, lanes 1-6) . However, CD2 crosslinking failed to induce these IkBa effects in the IKKg-deficient 5R/CD2.192LMP1 cells. The same lysates were then examined for the expression of p100 NF-kB2 and p52. Interestingly, despite the absence of IKKg, LMP1 oligomerization in 5R cells promoted the processing of p100 NF-kB2 to p52 (Figure 8b , lanes 7-12).
To confirm that this effect was not the result of artificially induced LMP1, 5R cells were stably transfected with WT LMP1 or, as a control, LMP1 carrying mutations in its cytoplasmic C-terminus that abolish TRAF and TRADD binding and render it inactive for NF-kB activation (LMP1 Eliopoulos et al., 2003) . Lysates from representative stable clones were examined for LMP1, p100 and p52 expression by immunoblot. As shown in Figure 8c (lanes 3-5) , constitutive expression of WT LMP1 in 5R cells results in increased proteolysis of endogenous p100 NF-kB2 compared to cells transfected with LMP1
A Â A Â A / 378STOP (lane 2) or empty vector (lane 1).
Nuclear translocation of p65 but not p52 is abolished in cells lacking IKKg/NEMO
The effects of LMP1 on the mobilization of the p65 NFkB subunit in Rat-1 and 5R cells were examined by immunofluorescence microscopy. To this end, cells were transfected with GFP-tagged LMP1 or control GFP and stained for endogenous p65. GFP-LMP1 expression resulted in the characteristic formation of patches in both the cytoplasm and plasma membrane, which has also been reported by other investigators (Huen et al., 1985; Dawson et al., 2003; Lam and Sugden, 2003) . There was no difference between Rat-1 and 5R cells with respect to the localization of LMP1 (Figure 9 ). GFP-LMP1 induced the translocation of p65 to the nucleus of Rat-1 cells, while transfection of GFP alone had no effect (Figure 9a and data not shown) . Interestingly, however, expression of GFP-LMP1 in 5R cells failed to promote nuclear mobilization of p65, consistent with its inability to induce IkBa phosphorylation and degradation in the same cell line. We then examined whether LMP1-mediated p100 processing results in the localization of p52 to the nucleus of Rat-1 and 5R cells. For this purpose, cells were transfected with GFP-tagged LMP1 in the presence of a p100 NF-kB2 expression vector, and green (GFP) and red (p100 NF-kB2) fluorescence was visualized 24 h later. It was found that LMP1-transfected cells expressed nuclear p52 in both Rat-1 and 5R cells (Figure 9b) .
To confirm the ability of LMP1 to promote NF-kB2 processing in an IKKg/NEMO-independent manner, nuclear proteins from anti-CD2-stimulated Rat-1/ CD2.LMP1 or 5R/CD2.192LMP1 cells were analysed for endogenous p52, RelB and p65 levels by immunoblot. The results showed that the absence of IKKg/ NEMO compromises the nuclear translocation of p65 but not p52 or RelB in LMP1-expressing cells (Figure 10 ).
Discussion
The Rel/NF-kB family of transcription factors plays a critical role in the regulation of innate and adaptive immunity, cell growth, differentiation and survival. Thus, it is not surprising that viruses, including EBV, often utilize this signalling pathway to prolong the lifespan and promote the transformation of infected cells (reviewed by Damania et al., 2000; Santoro et al., 2003) . The EBV-encoded LMP1 is the major effector of EBV-induced NF-kB and this activity appears to be responsible for many of its pleiotropic in vitro effects, including the ability to transform fibroblast cell lines, to upregulate a number of antiapoptotic proteins and to induce the expression of angiogenic factors and cell surface markers associated with motility and invasion (Cahir-McFarland et al., 1999; Eliopoulos and Young, 2001) .
LMP1 promotes the phosphorylation and degradation of IkBa resulting in the translocation of p65/p50 dimers to the nucleus and transactivation of a plethora of target genes. In this study, we show that in addition to the canonical IkBa-p65/p50 NF-kB pathway, LMP1 induces the proteasome-mediated proteolysis of the p100 NF-kB2 inhibitor to generate p52. This event results in the nuclear translocation of p52 in complex with p65 and RelB ( Figure 5 ). Although p52-containing heterodimers represent only a fraction of the total NF-kB activity induced by LMP1 in our experimental A total of 25 mg of nuclear proteins (lanes 2-5) isolated from these cultures was examined for endogenous p65, p52, RelB, SP1 and b-tubulin levels by immunoblot. Total Rat-1 cell extracts (15 mg) (whole-cell lysates, wcl; lane 1) were used as positive control for the detection of these proteins systems ( Figure 5 ), p100 processing is likely to play an important role in regulating at least some of the LMP1-mediated effects in vitro and in vivo, a possibility that is supported by our finding that LMP1-induced NF-kB transactivation is significantly reduced in fibroblasts from nf-kb2 À/À mice ( Figure 6 ). Moreover, genetic evidence suggests that p52 performs functions that cannot be replaced by p50 or other NF-kB members, an observation that can be explained in part by the differential affinity of NF-kB subunits for different but related kB DNA sequences (reviewed by Perkins, 1997) . In addition, the slower kinetics of nuclear translocation of p52 and RelB versus p65 in LMP1-expressing cells raises the possibility that different NF-kB heterodimers may have distinct roles in regulating LMP1 target gene expression. In agreement with this notion, the discernible defects in splenic architecture and generation and maintenance of germinal centers that characterize the p100 NF-kB2 knockout mice do not occur in animals lacking p105 NF-kB1 (Caamano et al., 1998; Franzoso et al., 1998) . Recent studies also suggest a specific role for p52 as an antiapoptotic protein capable of inducing the expression of Bcl-2 Viatour et al., 2003) and highlight its physiological contribution to early transitional IgM þ /CD21 À B-cell survival (Claudio et al., 2002) . Interestingly, LMP1 induces the expression of this antiapoptotic protein in lymphoid cells (Henderson et al., 1991) and this effect may be under the control of the p100 NF-kB2 pathway. The expression of LMP1 is key to the ability of EBV to colonize efficiently memory B cells, and activation of p100 processing may contribute to the establishment of virus persistence. Furthermore, loss of p100 or overexpression of p52 has been associated with lymphoid hyperplasia and epithelial transformation (Ishikawa et al., 1997; Rayet and Gelinas, 1999; Cogswell et al., 2000) and it is possible that the constitutive induction of p100 NF-kB2 processing may be part of the oncogenic mechanism of LMP1. The relatively slow kinetics of LMP1-induced p100 processing further supports a role for this process in contributing to the phenotypic consequences of constitutive LMP1 expression. These possibilities are highlighted by the strong correlation between the expression of LMP1 and the nuclear accumulation of p52 in primary biopsies from Hodgkin's lymphoma and NPC patients (Figure 2) .
The nfkb2 À/À mice share significant phenotypic similarities with the CD40, B-cell-activating factor (BAFF) and LTbR knockout animals (Kawabe et al., 1994; Matsumoto et al., 1996; Schiemann et al., 2001) . Interestingly, recent work has shown that activation of the CD40, BAFF or LTbR induces the processing of p100 (Claudio et al., 2002; Coope et al., 2002; Dejardin et al., 2002) . However, not all NF-kB-inducing stimuli engage this signalling pathway. Thus, the inability of interleukin 1, TNF and phorbol esters to promote the generation of p52 in a variety of target cells (Coope et al., 2002; Dejardin et al., 2002) suggests that the molecular components that regulate IkBa degradation and p100 processing differ. In this regard, it is of interest that mice bearing the alymphoplasia NIK mutation or animals lacking NIK or IKKa, are characterized by defects in splenic architecture and absence of lymph nodes, similar to the nf-kb2 À/À mice (Koike et al., 1996; Kaisho et al., 2001; Yin et al., 2001) . Concomitantly, while overexpressed NIK activates the IKK complex and stimulates both the IkBa and p100 pathways (Lin et al., 1998; Ling et al., 1998; Xiao et al., 2001b) , it is dispensable for IkBa degradation induced by a variety of cytokines and proinflammatory stimuli in a cell type-dependent manner (Garceau et al., 2000; Matsushima et al., 2001) . Unlike WT NIK, the aly mutant or a mutated NIK carrying only the TRAF-interacting domain ) fail to process p100 and have deleterious consequences for the ability of BAFF, CD40L or LTb to stimulate the generation of p52 (Xiao et al., 2001b; Claudio et al., 2002; Coope et al., 2002; Dejardin et al., 2002) . These effects have been attributed to the inability of aly NIK to interact with IKKa (Luftig et al., 2001) . Indeed, in cells lacking this IKK subunit, p100 processing in response to BAFF or LTb stimulation is impaired. Conversely, while the absence of IKKb or IKKg compromises the ability of these ligands to induce IkBa phosphorylation and degradation, p100 proteolysis is intact (Senftleben et al., 2001; Claudio et al., 2002; Dejardin et al., 2002) .
In this study, we provide the first evidence for the physiological role of the IKK complex in LMP1-mediated NF-kB signalling. Using fibroblasts lacking IKKg, we show that formation of the prototypic IKK molecular complex is required for LMP1-induced IkBa phosphorylation and degradation but not p100 processing ( Figure 8) . As a result, nuclear translocation of p52, but not p65, occurs in the absence of IKKg (Figures 9  and 10 ). This finding further supports the notion that IKKg is not a universal integrator of all NF-kB activities and points to the existence of alternative pathways that regulate NF-kB in LMP1-expressing cells. In this regard, the mechanisms by which LMP1 and other viral proteins, such as the human T-cell leukemia virus-encoded protein Tax or the equine herpesvirus-2 product vCLAP, induce p100 processing differ. Both Tax and vCLAP have been shown to interact directly with the IKK complex and to promote both IkBa degradation and p100 processing via a pathway that critically depends on IKKg/NEMO (Kanno et al., 1994; Poyet et al., 2001; Xiao et al., 2001a) . However, LMP1 does not bind the IKK complex directly and mediates NF-kB signalling via adapter proteins of the TRAF family capable of recruiting NIK and IKKs (Sylla et al., 1998) . We have found that overexpression of a NIK mutant that contains only the TRAF-interacting domain of NIK and is known to suppress LMP1-mediated NF-kB transcriptional activity (Luftig et al., 2001) , abolished the effects of LMP1 on p100 processing (Figure 7) . Therefore, the recruitment of an NIK-dependent but IKKg-independent signalling complex to LMP1 mediates the activation of the atypical p100 NF-kB2 pathway. The precise composition of this complex and the regulation of its function will be an interesting area for future studies.
Materials and methods
Plasmids, cell lines and culture media GFP-tagged LMP1 and the inducible CD2. 192LMP1 chimaera (Floettmann and Rowe, 1997) were kind gifts from Professor Martin Rowe, Cardiff, UK. RSV-p100 NF-kB2 was a generous gift from Dr Neil Perkins, University of Dundee, UK. NIKD contains aa 624-947 of human NIK and was PCR amplified from a WT NIK-containing plasmid (kindly provided by Dr D Wallach, Rehovot, Israel; Malinin et al., 1997), as previously described (Luftig et al., 2001) . It was then cloned as a BamHI/EcoRI fragment in frame into pRK5myc (Lamarche et al., 1996) Transfections and reporter assays SV40-immortalized MEF cell lines were plated out at 4 Â 10 5 cells in a 60 mm dish and the next day they were transfected with 100 ng of the NF-kB-responsive luciferase reporter 3Enh.kB-ConALuc that contains three tandem repeats of the NF-kB sites from the Igk promoter, 300 ng of b-galactosidase and 150 ng of pSG5-LMP1 or control vector using Lipofectamine Plus in Optimem media (Invitrogen Corp.) . Following a 12 h incubation with the transfection cocktail, the media were changed to DMEM supplemented with 10% FCS. Luciferase and b-gal values were measured 24 h later, as previously described (Eliopoulos et al., 1999 (Eliopoulos et al., , 2002a .
Preparation of nuclear extracts and EMSAs
Cells were resuspended in five volumes of homogenization buffer (10 mM HEPES-KOH pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT) supplemented with protease inhibitors (0.1 mM sodium orthovanadate, 10 mM sodium glycerophosphate, 2 mg/ml leupeptin and 2 mg/ml aprotinin) and centrifuged at 1200 rpm for 10 min. The pellet was resuspended in 3 volumes ice-cold homogenization buffer containing 0.05% NP40 and cells were homogenized with 15-20 strokes of a tight-fiting Dounce homogenizer on ice. Following centrifugation for 10 min at 1200 r.p.m. at 41C, the cytoplasmic fraction was collected. The nuclei were washed once with homogenization buffer and then resuspended in buffer containing 40 mM HEPES-KOH pH 7.9, 0.4 M KCl, 1 mM DTT and 10% glycerol with protease inhibitors. NaCl was added at a final concentration of 300 mM, mixed and the suspension was incubated on ice for 30 min and then centrifuged at 24 000 r.p.m. for 30 min. The supernatants were removed and snap-frozen. The EMSAs using the HIV LTR and CREB/ COX-2 probes were performed as previously described (Eliopoulos et al., 1999 (Eliopoulos et al., , 2002b 
Immunoblotting and immunoprecipitation
LMP1 expression was detected in 30 mg of total cell lysates analysed on a 10% gel using the anti-LMP1 mAbs CS.1-4 (Rowe et al., 1987) . A mouse mAb raised against aa 1-144 of human p100 NF-kB2 (Upstate Biotechnology) was used at 1 : 1000 dilution to detect p100 and p52 in 30 mg of total cell lysates. A mouse mAb raised against aa 1-82 of mouse p100 NF-kB2 (Caamano et al., 1996) was used at 1 : 1000 dilution to detect p100 and p52 in 20 mg of total cell lysates. Polyclonal antibodies against SP1 (PEP-2), IkBa (C-21), RelB (C-19), p65 (C-20) and cRel (B-6) were purchased from Santa-Cruz Biotechnology. IkBa and JNK phosphorylation was examined in 20 mg lysates, using phosphospecific IkBa (Ser32) and JNK (Thr 183 /Tyr 185 ) antibodies, respectively (Cell Signalling Technology). An mAb against b-tubulin was purchased from Santa Cruz and used at 1 : 1000 dilution. Proteins were electrotransferred to Biotrace nitrocellulose membranes (Pall Gelman Laboratory, Ann Arbor, USA), with the exception of experiments involving the detection of phosphorylated IkBa and JNK where resolved proteins were transferred to PVDF membranes (Biorad). Following incubation with primary antibodies and secondary HRP-labelled immunoglobulins, proteins were detected by enhanced chemiluminescence (ECL, Amersham, UK). For immunoprecipitation, 150 mg nuclear extracts was incubated for 4 h with 2 mg RelB, p65 or SP1 antibodies and the precipitated proteins were analysed by immunoblot.
Cell labelling and pulse-chase assays HEK 293EcR/LMP1 cells were treated with 10 mM ponasterone A for 18 h or left untreated. Cells were washed twice in phosphate-buffered saline (PBS) and once in methionine/ cysteine-free DMEM (Sigma) and then incubated for 30 min in the latter media. Cells were metabolically labelled with 0.2 mCi/ml 35 S-methionine/cysteine protein labelling mix (NEN) for 45 min, washed with PBS and complete DMEM and then chased for various time intervals. RIPA lysates were immunoprecipitated overnight with a mouse mAb raised against aa 1-144 of human p100 NF-kB2 (Upstate Biotechnology) and radiolabelled immunoprecipitated p100 and p52 were fractionated by SDS-PAGE and visualized by autoradiography.
Immunofluorescence microscopy
For immunofluorescence microscopy, Rat-1 and 5R cells were plated on slides and transfected with 80 ng DNA (GFP-LMP1 and/or p100 NF-kB2 or GFP alone) per 10 4 cells, using lipofectamine Plus (Invitrogen). After 24 h, the slides were washed in PBS and fixed in 4% paraformaldehyde in PBS for 20 min at room temperature (RT). Following extensive washing in PBS (10 min, RT), cells were permeabilized in 0.1% Triton X-100 in PBS for exactly 3 min and then washed again in PBS for 5 min at RT. Cells were then incubated with primary antibodies anti-p65 (C-20, Santa-Cruz Biotechnology) or anti-p100 NF-kB2 at 1 : 50 dilution in PBS supplemented with 10% heat-inactivated goat serum (HINGS) for 1 h at 371C in a humidified chamber. Following extensive washing in PBS, the cells were incubated for 45 min with Alexa Fluor 594 anti-rabbit or anti-mouse IgG (Molecular Probes, Leiden, Netherlands), respectively, at 1 : 500 dilution in PBS supplemented with 10% HINGS. Following a 10 min wash in PBS, slides were mounted with DABCO antifade reagent and red fluorescence was visualized on a Nikon E600 digital microscope.
Immunohistochemical staining
Sections of paraffin-embedded tissues were cut at 4 mm thicknesses onto microscope slides treated with Vectabond Reagent (Novocastra Laboratories Ltd, Newcastle upon Tyne, UK). Sections were dewaxed in xylene and rehydrated in ethanol. Endogenous peroxidase activity was blocked by a 10 min incubation in 3% hydrogen peroxide in methanol. Antigen retrieval was achieved for LMP1 IHC by microwaving slides in citric acid buffer (pH 5.8) for 10 min. No microwaving was required for p100/p52 IHC. Following a 10 min incubation in normal blocking serum (Dako Ltd, Cambridgeshire, UK) for LMP1, sections were incubated with appropriately diluted primary antibody for 1 h. LMP1 (CS 1-4, mouse monoclonal) was diluted 1 : 50 in PBS and p100/p52 was diluted 1 : 100 with PBS. Slides were washed with PBS then incubated for 30 min with biotinylated secondary antibody diluted 1 : 200 (Dako Ltd, Cambridgeshire, UK). Following another wash in PBS, slides were incubated for 30 min with streptavidin-peroxidase conjugate (Dako Ltd, Cambridgeshire, UK). Visualization was carried out using the Sigma Fast DAB substrate system (Sigma-Aldrich Company Ltd, Dorset, UK) for 10 min, and then slides were counterstained with hematoxylin, dehydrated and mounted for microscopic analysis.
